Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Pandemic Influenza A/H1N1 Produced by Sanofi.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 30 Mar 2012
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- 30 Mar 2012 Actual initiation date (Jun 2010) added as reported by ClinicalTrials.gov.
- 30 Mar 2012 Planned end date changed from 1 Dec 2010 to 1 Jul 2010 as reported by ClinicalTrials.gov.
- 30 Mar 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.